Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Acta Physiol (Oxf). 2015 Nov 11;216(3):358–375. doi: 10.1111/apha.12622

Figure 1.

Figure 1

Pilot experiment to find the optimal dose of Ki16425 for treatment of experimental BPD by determining the pulmonary influx of ED-1-positive monocytes and macrophages in tissue sections in room air (RA), pups injected daily with DMSO (10%, open bar) and O2-exposed pups (O2) injected daily with 10% DMSO or Ki16425 (shaded bars): 1, 2.5 and 5 mg kg−1 day−1. Data are expressed as mean ± SEM. ***p < 0.001 versus RA control. ††p <0.01 and †††p < 0.001 versus age-matched DMSO-treated O2-exposed control; n=4-8 per group.